![Kimberlee Drapkin](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Kimberlee Drapkin
Directeur/Membre du Conseil chez
CLIMB BIO, INC.
Fortune : 36 003 $ au 31/05/2026
Profil
Kimberlee Cobleigh Drapkin currently serves as Independent Director at Acumen Pharmaceuticals, Inc. since 2022, Independent Non-Executive Director at Imugene Ltd. since 2023, Director at Lucy Therapeutics, Inc. since 2024, Independent Director at Climb Bio, Inc. starting 2025, Independent Director at LENZ Therapeutics, Inc. since 2023, and Member at Dana-Farber Cancer Institute, Inc. Former roles include President, CEO, CFO, Director & PAO at Graphite Bio, Inc. from 2023 to 2024; Independent Director at Proteostasis Therapeutics, Inc. from 2019 to 2020; Independent Director at Kineta, Inc. from 2023 to 2025; Independent Director at Yumanity Therapeutics, Inc. from 2019 to 2022; Director at Yumanity, Inc. from 2020 to 2022; Principal at Millennium Pharmaceuticals, Inc. from 1995 to 2005; Chief Financial Officer at EPIX Pharmaceuticals, Inc. from 2006 to 2009; Principal at PricewaterhouseCoopers LLP; Chief Financial Officer at Predix Pharmaceuticals, Inc., NinePoint Medical, Inc., Avila Therapeutics, Inc., Edimer Pharmaceuticals, Inc., Sesen Bio, Inc., Blueprint Medicines Corp., Warp Drive Bio, Inc., and Voyager Therapeutics, Inc.; Chief Financial Officer at Predix Pharmaceuticals Holdings, Inc. from 2005 to 2006; President, Chief Financial Officer & Treasurer at Jounce Therapeutics, Inc. in 2023; Chief Financial Officer & Owner at Kcd Financial Consultants LLC from 2012 to 2015.
Education includes undergraduate studies at Babson College.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 03/06/2026 | 12 800 ( 0,02 % ) | 33 280 $ | 31/05/2026 | |
IMUGENE LTD 0,01 % | 17/12/2025 | 32 914 ( 0,01 % ) | 2 723 $ | 31/05/2026 |
-.--% | 14/04/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
CLIMB BIO, INC. -.--% | 05/06/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
Postes actifs de Kimberlee Drapkin
| Sociétés | Poste | Début |
|---|---|---|
| ACUMEN PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 01/04/2022 |
| IMUGENE LIMITED | Directeur/Membre du Conseil | 21/06/2023 |
| CLIMB BIO, INC. | Directeur/Membre du Conseil | 28/03/2025 |
Lucy Therapeutics, Inc.
 Lucy Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops molecular therapies for mitochondrial diseases | Directeur/Membre du Conseil | 01/10/2024 |
Dana-Farber Cancer Institute, Inc.
 Dana-Farber Cancer Institute, Inc. Hospital/Nursing ManagementHealth Services Provides treatment to cancer patients | Corporate Officer/Principal | - |
Anciens postes connus de Kimberlee Drapkin
| Sociétés | Poste | Fin |
|---|---|---|
| KINETA, INC. | Directeur/Membre du Conseil | 30/06/2025 |
| LENZ THERAPEUTICS, INC. | Directeur Général | 01/03/2024 |
| JOUNCE THERAPEUTICS, INC. | President | 03/05/2023 |
Yumanity, Inc.
 Yumanity, Inc. Pharmaceuticals: MajorHealth Technology Provides transforming drug discovery for neurodegenerative diseases services | Directeur/Membre du Conseil | 01/12/2022 |
| ░░░░░░░░ ░░░░░░░░░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
Formation de Kimberlee Drapkin
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
72
Relations au 1er degré
25
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 25 |
|---|---|
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Health Technology |
EPIX Pharmaceuticals, Inc.
 EPIX Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Develops pharmaceuticals | Health Technology |
PricewaterhouseCoopers LLP
 PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services Provides auditing, assurance, consulting and tax & business consulting services | Commercial Services |
Acumen Pharmaceuticals, Inc.
 Acumen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops medicines and diagnostics for Alzheimer's disease | Health Technology |
Predix Pharmaceuticals, Inc.
 Predix Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Developes novel drugs and other related products | Health Technology |
NinePoint Medical, Inc.
 NinePoint Medical, Inc. Medical SpecialtiesHealth Technology Develops and manufactures imaging tool in evaluation of human tissue microstructure | Health Technology |
Dana-Farber Cancer Institute, Inc.
Dana-Farber Cancer Institute, Inc. Hospital/Nursing ManagementHealth Services Provides treatment to cancer patients | Health Services |
Imugene Ltd.
 Imugene Ltd. BiotechnologyHealth Technology Operates as a a clinical stage immuno-oncology company | Health Technology |
Babson College
 Babson College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Predix Pharmaceuticals Holdings, Inc.
 Predix Pharmaceuticals Holdings, Inc. Pharmaceuticals: MajorHealth Technology Discovers and developes novel, highly selective, small-molecule drugs | Health Technology |
Avila Therapeutics, Inc.
 Avila Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Researches and develops covalent drugs | Health Technology |
Proteostasis Therapeutics, Inc.
 Proteostasis Therapeutics, Inc. BiotechnologyHealth Technology Develops disease-modifying therapeutics for orphan and neurodegenerative diseases | Health Technology |
Edimer Pharmaceuticals, Inc.
 Edimer Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Provides biopharmaceutical products for improving the health and quality of life of families living with XLHED | Health Technology |
Sesen Bio, Inc.
 Sesen Bio, Inc. Pharmaceuticals: MajorHealth Technology Develops protein therapeutics to treat eye diseases | Health Technology |
Blueprint Medicines Corp.
 Blueprint Medicines Corp. BiotechnologyHealth Technology Develops cancer therapies that harness the growing understanding of the molecular blueprint of cancer | Health Technology |
Warp Drive Bio, Inc.
 Warp Drive Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Focuses on proprietary genomic technology to discover drugs of natural origin | Commercial Services |
Jounce Therapeutics, Inc.
 Jounce Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage immunotherapy company that develops therapies to treat cancer | Health Technology |
Voyager Therapeutics, Inc.
 Voyager Therapeutics, Inc. BiotechnologyHealth Technology Develops gene therapies for fatal and debilitating diseases of the central nervous system | Health Technology |
Yumanity, Inc.
Yumanity, Inc. Pharmaceuticals: MajorHealth Technology Provides transforming drug discovery for neurodegenerative diseases services | Health Technology |
Kcd Financial Consultants LLC
 Kcd Financial Consultants LLC Investment ManagersFinance Provides financial consulting services | Finance |
Eliem Therapeutics, Inc.
 Eliem Therapeutics, Inc. BiotechnologyHealth Technology Operates as clinical-stage biotechnology company focused on developing novel therapies for neuronal excitability disorders | Health Technology |
Lucy Therapeutics, Inc.
Lucy Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops molecular therapies for mitochondrial diseases | Health Technology |
Graphite Bio, Inc.
 Graphite Bio, Inc. BiotechnologyHealth Technology Operates as gene editing company for DNA integrations | Health Technology |
Yumanity Therapeutics, Inc.
 Yumanity Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
Kineta, Inc.
 Kineta, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
